资讯

After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has ...
Coronary artery disease, a major cause of heart attacks, often develops silently. Key warning signs include chest discomfort, ...
Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...
The Maine Forest Service reported the first deaths of beech trees caused by beech leaf disease earlier this month.
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
过去二十年,几乎所有进入临床试验的阿尔茨海默病(Alzheimer’s disease, AD)新药都以失败告终,失败率高达99%。这让阿尔茨海默病一度被称为“新药研发的黑洞”。 然而,2025年8月6日《Molecular ...
"When children get this kind of very severe [Valley fever,] it's very devastating," Yang said, explaining that infection can ...
Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...
With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...
A fourth person has died in connection with a Legionnaires’ disease outbreak in New York City. Health officials disclosed the ...
Health officials in New York City say a cluster of Legionnaires’ disease in Central Harlem has grown to 101 cases, including ...
There are now 108 confirmed cases of the potentially deadly form of pneumonia in Harlem since late July, NYC officials said.